Life Sciences Tools and Services
Company Overview of RP Management, LLC
RP Management, LLC acquires royalty interests in marketed and late stage pharmaceutical and biopharmaceutical products. The company owns royalty interests in various approved and marketed biopharmaceutical products, and products in clinical trials and/or under review with the United States Food and Drug Administration and/or the European Medicines Agency. Its portfolio includes various products for cancer; rheumatoid arthritis and psoriasis; B-cell lymphoma, multiple sclerosis, and lupus; human immunodeficiency virus/acquired immune deficiency syndrome; multiple myeloma; diabetic peripheral neuropathy, postherpetic neuralgia, and onset seizures and fibromyalgia; pulmonary arterial hypertensi...
110 East 59th Street
New York, NY 10022
Founded in 1996
Key Executives for RP Management, LLC
Co-Founder, Chief Executive Officer and Member of Investment Committee
Co-Founder, Chairman and Chairman of Investment Committee
Chief Financial Officer and Executive Vice President
Head of Research & Investments and Executive Vice President
Executive Vice President of Investments and General Counsel
Compensation as of Fiscal Year 2015.
RP Management, LLC Key Developments
RP Management, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 12:00 PM
Nov 8 15
RP Management, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 12:00 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States.
RP Management, LLC Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM
Apr 23 15
RP Management, LLC Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM. Venue: 2025 Ave Of The Stars, Los Angeles, CA 90067, California, United States. Speakers: Pablo Legorreta, Co-Founder, Chief Executive Officer and Member of Investment Committee.
Royalty Pharma Appoints Greg Norden to its Investment Committee
Jan 15 15
Royalty Pharma announced that Greg Norden has joined its Investment Committee. Greg brings more than 25 years of leadership experience in financial management and more than 20 years of experience in global healthcare and pharmaceuticals. Greg is currently the Managing Director of G9 Capital Group, LLC, which invests in early stage ventures and provides corporate advisory services.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|